Skip to main content
. 2021 Mar 12;62:100060. doi: 10.1016/j.jlr.2021.100060

Fig. 3.

Fig. 3

Clinical algorithm for LDL-cholesterol lowering in patients with homozygous familial hypercholesterolemia. ASCVD, atherosclerotic cardiovascular disease; PCSK9, proprotein convertase subtilisin Kexin type 9.